BLND vs. OSCR
BLND (Blend Labs, Inc.) and OSCR (Oscar Health, Inc.) are both stocks. BLND operates in Software - Application (Technology), while OSCR operates in Healthcare Plans (Healthcare). Over the past 3 years, BLND returned 20.39%/yr vs 43.86%/yr for OSCR. At a 0.27 correlation, their price movements are largely independent.
Performance
BLND vs. OSCR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BLND achieves a -43.75% return, which is significantly lower than OSCR's 90.61% return.
BLND
- 1D
- 5.56%
- 1M
- 23.91%
- YTD
- -43.75%
- 6M
- -46.89%
- 1Y
- -54.28%
- 3Y*
- 20.39%
- 5Y*
- —
- 10Y*
- —
OSCR
- 1D
- 11.75%
- 1M
- 28.53%
- YTD
- 90.61%
- 6M
- 63.72%
- 1Y
- 77.63%
- 3Y*
- 43.86%
- 5Y*
- -0.71%
- 10Y*
- —
BLND vs. OSCR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BLND Blend Labs, Inc. | -43.75% | -27.79% | 65.10% | 77.08% | -80.38% | -64.88% |
OSCR Oscar Health, Inc. | 90.61% | 6.92% | 46.89% | 271.95% | -68.66% | -59.49% |
Correlation
The correlation between BLND and OSCR is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 19, 2021 | 0.27 |
Fundamentals
BLND:
$437.13M
OSCR:
$9.03B
BLND:
-$0.04
OSCR:
-$0.14
BLND:
3.49
OSCR:
0.59
BLND:
$127.59M
OSCR:
$13.30B
BLND:
$95.50M
OSCR:
$895.79M
BLND:
-$16.09M
OSCR:
$19.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BLND vs. OSCR — Risk / Return Rank
BLND
OSCR
BLND vs. OSCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Blend Labs, Inc. (BLND) and Oscar Health, Inc. (OSCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BLND | OSCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.76 | ||
| Sortino ratioReturn per unit of downside risk | -2.77 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.22 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 1.51 | -2.30 |
| Martin ratioReturn relative to average drawdown | -1.33 | 2.80 | -4.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BLND | OSCR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.76 | 1.00 | -1.76 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.01 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.48 | -0.06 | -0.42 |
Drawdowns
BLND vs. OSCR - Drawdown Comparison
The maximum BLND drawdown since its inception was -97.37%, roughly equal to the maximum OSCR drawdown of -94.15%. Use the drawdown chart below to compare losses from any high point for BLND and OSCR.
Loading charts...
Drawdown Indicators
| BLND | OSCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.37% | -94.15% | -3.22% |
Max Drawdown (1Y)Largest decline over 1 year | -68.42% | -51.71% | -16.71% |
Max Drawdown (3Y)Largest decline over 3 years | -74.21% | -53.39% | -20.82% |
Max Drawdown (5Y)Largest decline over 5 years | — | -91.82% | — |
Current DrawdownCurrent decline from peak | -91.82% | -25.51% | -66.31% |
Average DrawdownAverage peak-to-trough decline | -81.10% | -65.12% | -15.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 40.92% | 27.80% | +13.12% |
Volatility
BLND vs. OSCR - Volatility Comparison
Blend Labs, Inc. (BLND) has a higher volatility of 28.87% compared to Oscar Health, Inc. (OSCR) at 25.40%. This indicates that BLND's price experiences larger fluctuations and is considered to be riskier than OSCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BLND | OSCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.87% | 25.40% | +3.47% |
Volatility (6M)Calculated over the trailing 6-month period | 54.77% | 45.69% | +9.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.61% | 78.49% | -6.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 84.43% | 80.69% | +3.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.43% | 80.06% | +4.37% |
Dividends
BLND vs. OSCR - Dividend Comparison
Neither BLND nor OSCR has paid dividends to shareholders.
Financials
BLND vs. OSCR - Financials Comparison
This section allows you to compare key financial metrics between Blend Labs, Inc. and Oscar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BLND vs. OSCR - Profitability Comparison
BLND - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Blend Labs, Inc. reported a gross profit of 23.37M and revenue of 30.84M. Therefore, the gross margin over that period was 75.8%.
OSCR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a gross profit of 0.00 and revenue of 4.65B. Therefore, the gross margin over that period was 0.0%.
BLND - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Blend Labs, Inc. reported an operating income of -5.06M and revenue of 30.84M, resulting in an operating margin of -16.4%.
OSCR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported an operating income of 704.09M and revenue of 4.65B, resulting in an operating margin of 15.2%.
BLND - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Blend Labs, Inc. reported a net income of -12.78M and revenue of 30.84M, resulting in a net margin of -41.4%.
OSCR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a net income of 679.00M and revenue of 4.65B, resulting in a net margin of 14.6%.
Frequently Asked Questions
BLND and OSCR have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BLND has higher volatility (28.87%) compared to OSCR (25.40%). In terms of maximum drawdown, BLND dropped -97.37% vs OSCR's -94.15%.
OSCR currently has the higher Sharpe Ratio (1.00 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BLND and OSCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer